Literature DB >> 26823813

Primary bone natural killer/T cell lymphoma, nasal type without EBV infection: a case report.

Chen Tian1, Yafei Wang1, Lei Zhu1, Yong Yu1, Yizhuo Zhang1.   

Abstract

Primary bone NK/T cell lymphoma is very rare. We report a case of 52-year-old man of primary bone NK/T cell lymphoma and then progressed to NK leukemia. The patient had low-grade fever for 4-month, and Ultrasonic B revealed a diffuse hepatosplenomegaly without lymphadenopathy. PET scanning showed increased FDG uptake in many bones of the whole body. The diagnosis was established by bone specimen. These neoplastic cells demonstrated a typical immunophenotype of CD56, CD3, CD2 and MPO positive, and CD5, CD20, CD30, PAX-5, CD4 and CD8 negative. Primary bone ENKTL is very rare; it should be made with the combination of clinical feature, PET-CT image, and pathological characteristics, and should be distinguished from other lymphomas or leukemia involved in bone.

Entities:  

Keywords:  NK/T cell lymphoma; Primary bone; SMILE regimen

Mesh:

Year:  2015        PMID: 26823813      PMCID: PMC4713599     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.

Authors:  Huiqiang Huang; Zexiao Lin; Xubin Lin; Qingqing Cai; Zhongjun Xia; Wenqi Jiang
Journal:  Leuk Lymphoma       Date:  2011-06

2.  Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.

Authors:  Fumihiro Ishida; Young Hyeh Ko; Won Seog Kim; Junji Suzumiya; Yasushi Isobe; Kazuo Oshimi; Shigeo Nakamura; Ritsuro Suzuki
Journal:  Cancer Sci       Date:  2012-03-23       Impact factor: 6.716

3.  Effectiveness of gemcitabine, pegaspargase, cisplatin, and dexamethasone (DDGP) combination chemotherapy in the treatment of relapsed/refractory extranodal NK/T cell lymphoma: a retrospective study of 17 patients.

Authors:  Zhiyuan Zhou; Xiang Li; Changying Chen; Xin Li; Lei Zhang; Ling Li; Xinhua Wang; Wang Ma; Xiaorui Fu; Jingjing Wu; Zhenchang Sun; Xudong Zhang; Zhaoming Li; Jiaqin Yan; Yu Chang; Lisha Lu; Beibei Qin; Xiaoli Li; Jianguo Wen; Mingzhi Zhang
Journal:  Ann Hematol       Date:  2014-06-13       Impact factor: 3.673

4.  Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.

Authors:  Neng-Gang Jiang; Yong-Mei Jin; Qian Niu; Ting-Ting Zeng; Jun Su; Huan-Ling Zhu
Journal:  Ann Hematol       Date:  2012-09-20       Impact factor: 3.673

5.  Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yoshinori Ito; Hiroshi Kimura; Yoshinobu Maeda; Chizuko Hashimoto; Fumihiro Ishida; Koji Izutsu; Noriyasu Fukushima; Yasushi Isobe; Jun Takizawa; Yuichi Hasegawa; Hajime Kobayashi; Seiichi Okamura; Hikaru Kobayashi; Motoko Yamaguchi; Junji Suzumiya; Rie Hyo; Shigeo Nakamura; Keisei Kawa; Kazuo Oshimi; Ritsuro Suzuki
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

6.  Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type.

Authors:  Li Yang; Hong Liu; Xiao-hong Xu; Xin-feng Wang; Hong-ming Huang; Wen-yu Shi; Sheng-hua Jiang
Journal:  Med Oncol       Date:  2013-09-24       Impact factor: 3.064

7.  Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation.

Authors:  Toshiro Ito; Hideki Makishima; Hideyuki Nakazawa; Hikaru Kobayashi; Shigetaka Shimodaira; Yozo Nakazawa; Kiyoshi Kitano; Kazuyuki Matsuda; Eiko Hidaka; Fumihiro Ishida
Journal:  Eur J Haematol       Date:  2008-05-06       Impact factor: 2.997

8.  NK/T-cell lymphoma of bilateral adrenal glands in a patient with pyothorax.

Authors:  Tomohide Tsukahara; Akira Takasawa; Masaki Murata; Kazuyoshi Okumura; Masato Nakayama; Noriyuki Sato; Tadashi Hasegawa
Journal:  Diagn Pathol       Date:  2012-08-29       Impact factor: 2.644

Review 9.  An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature.

Authors:  QingPing Jiang; Shaoyan Liu; Juan Peng; Hanzhen Xiong; ZhongTang Xiong; Yuexin Yang; Xuexian Tan; Xingcheng Gao
Journal:  Diagn Pathol       Date:  2013-06-17       Impact factor: 2.644

10.  Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.

Authors:  Seok Jin Kim; Hyun Ae Jung; Shih-Sung Chuang; Huangming Hong; Cheng-Cheng Guo; Junning Cao; Xiao-Nan Hong; Ritsuro Suzuki; Hye Jin Kang; Jong Ho Won; Wee-Joo Chng; Yok-Lam Kwong; Cheolwon Suh; Yu-Qin Song; Jun Zhu; Kevin Tay; Soon Thye Lim; Junji Suzumiya; Tong-Yu Lin; Won Seog Kim
Journal:  J Hematol Oncol       Date:  2013-11-16       Impact factor: 17.388

View more
  1 in total

1.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.